ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

XGN Exagen Inc

1.40
0.015 (1.08%)
04 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Exagen Inc XGN 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.015 1.08% 1.40 09:00:00
개장가 저가 고가 종가 전일 종가
1.38 1.3606 1.42 1.40 1.385
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
01/05/202405:05GLOBEExagen to Announce First Quarter 2024 Results on May 13,..
26/04/202421:30GLOBEExagen Inc. Announces Changes to the Board of Directors
18/03/202421:00GLOBEExagen Inc. Reports Strong Fourth Quarter and Full-Year 2023..
18/03/202420:12IHMARKETNEWSAnticipation Builds on Wall Street for Federal Reserve’s..
08/03/202423:00GLOBEExagen Inc. to Participate in the KeyBanc Capital..
08/03/202406:05GLOBEExagen to Announce Fourth Quarter 2023 and Full-Year..
07/03/202406:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/03/202406:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/02/202406:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/02/202406:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/02/202421:12EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/02/202406:35EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
09/02/202406:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/02/202405:16EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
31/01/202406:05GLOBEExagen Inc. to Participate in the 2024 BTIG MedTech, Digital..
23/01/202406:15EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/01/202422:00EDGAR2Form 8-K - Current report
08/01/202402:00GLOBEExagen Inc. Announces Select Preliminary Full-Year 2023..
12/12/202306:05EDGAR2Form 8-K - Current report
30/11/202314:15EDGAR2Form EFFECT - Notice of Effectiveness
30/11/202307:11EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
28/11/202306:05EDGAR2Form S-3/A - Registration statement under Securities Act of..
20/11/202322:00EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
18/11/202306:30EDGAR2Form 8-K - Current report
18/11/202306:06EDGAR2Form S-3 - Registration statement under Securities Act of..
14/11/202307:24EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/11/202306:05EDGAR2Form 8-K - Current report
14/11/202306:05GLOBEExagen Inc. Reports Strong Third Quarter 2023 Results
10/11/202306:05GLOBEExagen Inc. and Johns Hopkins University Announce License..
03/11/202305:05GLOBEExagen Inc. to Participate in the 2023 Canaccord Genuity..
31/10/202305:05GLOBEExagen to Announce Third Quarter 2023 Financial Results on..
19/10/202305:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/10/202303:50DJNExagen Agrees to Pay Over $650K to Resolve Kickback..
29/09/202305:05GLOBEExagen Announces Acceptance of Multiple Abstracts at ACR..
13/09/202305:05GLOBEExagen Inc. to Participate in the 2023 Cantor Fitzgerald..
07/09/202306:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/08/202322:23EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/08/202321:00EDGAR2Form 8-K - Current report
07/08/202321:00GLOBEExagen Inc. Reports Strong Second Quarter 2023 Results
27/07/202305:05GLOBEExagen Inc. to Participate in the Canaccord Genuity 43rd..
26/07/202305:05GLOBEExagen to Announce Second Quarter 2023 Financial Results on..
25/07/202305:05EDGAR2Form 8-K - Current report
25/07/202305:05GLOBEExagen Inc. Appoints Paul Kim to Board of Directors
30/05/202322:00GLOBEExagen Inc. to Participate in the William Blair 43rd Annual..
16/05/202305:05GLOBEExagen Inc. Reports First Quarter 2023 Results

최근 히스토리

Delayed Upgrade Clock